eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations.
Valcikova B, Vadovicova N, Smolkova K, Zacpalova M, Krejci P, Lee S, Rauch J, Kolch W, von Kriegsheim A, Dorotikova A, Andrysik Z, Vichova R, Vacek O, Soucek K, Uldrijan S., Free PMC Article

Follicular cell-derived thyroid carcinomas harboring novel genetic BRAF(NON-V600E) mutations: real-world data obtained using a multigene panel.
von Ammon JL, Machado GJR, da Matta RRC, Telles AC, Carrijo F, Dos Santos BAF, Brandão JCD, da Silva TM, Hecht F, Colozza-Gama GA, Tezzei JH, Cerutti JM, Ramos HE., Free PMC Article

A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLC.
Liu D, Ding K, Yin K, Peng Z, Li X, Pan Y, Jin X, Xu Y., Free PMC Article

BRAF mutation in myeloid neoplasm: incidences and clinical outcomes.
Abuasab T, Mohamed S, Pemmaraju N, Kadia TM, Daver N, DiNardo CD, Ravandi F, Qiao W, Montalban-Bravo G, Borthakur G.

Decoding the Molecular Mechanisms of BRAF (V600E)-Induced Nevi Formation.
Liang WZ, Liu YX, Xu DD, Jiang WJ, Ran RS.

Analysis of Immunohistochemical Expression of BRAF (V600E) Mutation in Serrated Colorectal Polyps: A Study from Tertiary Hospital in Oman.
Al Ghafri A, Sayed SG, Al Badi S, Al Rashdi A, Al Husaini S, Qureshi A, Shalaby A., Free PMC Article

Non-canonical BRAF variants and rearrangements in hairy cell leukemia.
Langabeer SE., Free PMC Article

Variation in KRAS/NRAS/BRAF-Mutation Status by Age, Sex, and Race/Ethnicity Among a Large Cohort of Patients with Metastatic Colorectal Cancer (mCRC).
Booker BD, Markt SC, Schumacher FR, Rose J, Cooper G, Selfridge JE, Koroukian SM.

Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond.
Colombino M, Casula M, Paliogiannis P, Manca A, Sini MC, Pisano M, Santeufemia DA, Cossu A, Palmieri G.

RICTOR/mTORC2 downregulation in BRAF(V600E) melanoma cells promotes resistance to BRAF/MEK inhibition.
Ponzone L, Audrito V, Landi C, Moiso E, Levra Levron C, Ferrua S, Savino A, Vitale N, Gasparrini M, Avalle L, Vantaggiato L, Shaba E, Tassone B, Saoncella S, Orso F, Viavattene D, Marina E, Fiorilla I, Burrone G, Abili Y, Altruda F, Bini L, Deaglio S, Defilippi P, Menga A, Poli V, Porporato PE, Provero P, Raffaelli N, Riganti C, Taverna D, Cavallo F, Calautti E., Free PMC Article

Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L., Free PMC Article

Unraveling morphology, methylation profiling, and diagnostic challenges in BRAF-Mutant pediatric glial and glioneuronal tumors.
Alturkustani M., Free PMC Article

KRAS and BRAF genetic alterations in lung cancer: A case - control study.
Sawal HA, Shah SI, Malik SS, Mehmood S, Baig M, Rasool E, Masood N.

High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells.
Giraulo C, Orlando L, Morretta E, Voli A, Plaitano P, Cicala C, Potaptschuk E, Müller CE, Tosco A, Monti MC, Morello S.

Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
Toda S, Saito N, Kadoya M, Okubo Y, Yamazaki H, Suganuma N, Iwasaki H, Masudo K, Hoshino D.

Lymph Node Metastasis in Papillary Thyroid Carcinoma, A Study of BRAF V600E and TERT Promoter Mutations.
Soeratman AR, Kartini D, Andinata B, Harahap AS, Sudarsono NC., Free PMC Article

The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodules.
Lin Y, Cheng Y, Zhang Y, Ren X, Li J, Shi H, Li Y, Luo Y, Wang H.

Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.
Bezić J, Tomić I, Pavić M.

Associations of BRAF(V600E) mutation with the American College of Radiology Thyroid Imaging Reporting and Data System and clinicopathological characteristics in pediatric patients with papillary thyroid carcinoma.
Tan Y, Zhong J, Zheng T, Fu Y, Liu M, Wang G.

BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience.
Fei F, Caporale C, Chang L, Fortini BK, Ali H, Bell D, Stein A, Marcucci G, Telatar M, Afkhami M., Free PMC Article

KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients.
El Zaitouni S, Laraqui A, Ghaouti M, Benzekri A, Kettani F, Bajjou T, Sekhsokh Y, Benmokhtar S, Jafari M, Baba W, Oukabli M, El Annaz H, Abi R, Tagajdid MR, El Kochri S, Lahlou IA, Ameziane El Hassani R, Ennibi K., Free PMC Article

Deep neural network for the prediction of KRAS, NRAS, and BRAF genotypes in left-sided colorectal cancer based on histopathologic images.
Li X, Chi X, Huang P, Liang Q, Liu J.

Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.
Liu R, Zhu G, Tan J, Shen X, Xing M., Free PMC Article

Genomic deletions explain the generation of alternative BRAF isoforms conferring resistance to MAPK inhibitors in melanoma.
Aya F, Lanuza-Gracia P, González-Pérez A, Bonnal S, Mancini E, López-Bigas N, Arance A, Valcárcel J.

Differentiating BRAF V600E- and RAS-like alterations in encapsulated follicular patterned tumors through histologic features: a validation study.
Kim C, Agarwal S, Bychkov A, Hang JF, Harahap AS, Hirokawa M, Kakudo K, Keelawat S, Liu CY, Liu Z, Nguyen TP, Rana C, Vuong HG, Zhu Y, Jung CK.